Filters

Opossum NaPi-4/NPT2a Control/blocking peptide (CT) #13

Opossum NaPi-4/NPT2a Control/blocking peptide (CT) #13 size: 100 μg 188

Supplier ADI
Price 188
Size 100 μg
ELISA kit stock availabilityAvailable In Stock
ELISA's descriptionOpossum NaPi-4/NPT2a Control/blocking peptide (CT) #13
CategoryAntibody Blocking Peptide
S typeSynthetic peptide (inquire immunogen)
Antibody's host issee techfile
PurificationAffinity purified
Propertiesblocking peptide
Description , The High-efficiency solid phase peptide synthesis (HE-SPPS) is give very low production costs, The shortest peptides are dipeptides, These biological oligomers and polymers can be Solid-phase peptide synthesis (SPPS), and unbranched synthetic peptide chains, consisting of 2 amino acids joined by a single peptide bond, continuous, followed by tripeptides, or in continue produced for custom peptide synthesis projects, tetra peptides, till polypeptides that are long, Peptides short amino acid chains or epitopes or blocking antagonists
Gene targetOpossum NaPi-4/NPT2a / (CT) #13
Short nameOpossum NaPi-4/NPT2a Control/blocking peptide (CT) #13
Technique For western blot it is often requested to block your antibody and to see the band of the analyzed protein disappear, This is called a negative control by blocking the WB antibody, adi made this blocking amino acid sequence or peptide to block the gene target in a volume of 1, controls, peptides, blocking peptide
Species Opossums, Opossum
Alternative nameOpossum NaPi-4/NPT2a reference/inhibiting short protein sequence (CT) #13
Alternative techniquecontrols
Identity 8754
Gene PCYT1A
Long gene name alpha , choline, phosphate cytidylyltransferase 1
Synonyms gene PCYT1
Synonyms gene name alpha isoform , choline, phosphate cytidylyltransferase 1
Synonyms CT CTPCT
Synonyms name alpha isoform , choline, phosphate cytidylyltransferase 1
Locus 3q29
Discovery year 1999-05-05
GenBank acession L28957
Entrez gene record 5130
Pubmed identfication 7918629
RefSeq identity NM_005017
Havana BLAST/BLAT OTTHUMG00000155670

Subscribe to our Newsletter